- Presentations
- 4
- Markets
- 1
Miplyffa is a brand of Arimoclomol marketed by Acer Therapeutics, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Arimoclomol
- Brand owner
- Acer Therapeutics
- Registered in
- United States
- Strengths and forms
- 124 mg capsule, 47 mg capsule, 62 mg capsule, 93 mg capsule
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Miplyffa 124 mg capsuleOral | Acer Therapeutics | US FDA | Available on request |
| Miplyffa 47 mg capsuleOral | Acer Therapeutics | US FDA | Available on request |
| Miplyffa 62 mg capsuleOral | Acer Therapeutics | US FDA | Available on request |
| Miplyffa 93 mg capsuleOral | Acer Therapeutics | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Miplyffa
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.